Login / Signup

Development of solid lipid nanoparticles-loaded drugs in parasitic diseases.

Sara NematiMahsa MottaghiParisa KaramiHamed Mirjalali
Published in: Discover nano (2024)
Parasites cause illnesses with broad spectrum of symptoms from mild to severe, and are responsible for a significant number of outbreaks in the world. Current anti-parasitic drugs are toxic and have significant side effects. Nano-carriers are believed to obviate the limitations of conventional drugs via decreasing side effects and increasing target delivery and drug permeability with a controlled prolonged release of a drug. Solid lipid nanoparticles (SLNs) are lipid nanoparticles (LNPs), which have frequently been practiced. Suitable release rate, stability, and target delivery make SLNs a good alternative for colloidal carriers. SLNs are supposed to have great potential to deliver natural products with anti-parasitic properties. Nanoparticles have employed to improve stability and capacity loading of SLNs, during recent years. This review describes development of SLNs, the methods of preparation, characterization, and loaded drugs into SLNs in parasitic diseases. In addition, we summarize recent development in anti-parasitic SLNs-loaded drugs.
Keyphrases
  • drug delivery
  • drug induced
  • cancer therapy
  • wound healing
  • mass spectrometry
  • early onset
  • walled carbon nanotubes
  • depressive symptoms